SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001104659-19-070649
Filing Date
2019-12-06
Accepted
2019-12-06 17:01:25
Documents
1
Effectiveness Date
2019-12-06
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.1: Section 3(c)(1)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 9120
  Complete submission text file 0001104659-19-070649.txt   10292
Mailing Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND
Business Address 158-160 NORTH GOWER STREET LONDON X0 NW1 2ND 44 20 7932 2100
Advent Life Sciences Fund III LP (Filer) CIK: 0001761089 (see all company filings)

IRS No.: 981434136 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-327448 | Film No.: 191273712